From $49.99/mo · Free consult · 4.2★ on Trustpilot · All 50 States
814 verified reviews
Sublingual Tadalafil + Vardenafil dual-compound protocol — unusual PDE5 combination at mid-tier pricing, useful for users where standard sildenafil/tadalafil monotherapy hasn't worked.
Complete the Maximus ED intake — symptom pattern, cardiovascular history, prior PDE5 inhibitor response (if any), current medications (nitrate screening), and treatment goals. Free physician consult; most prescriptions written within 24–48 hours.
First medication shipment lands within 3–5 days of script approval (free priority shipping). Start with the prescribed protocol — Tadalafil-only as standard first-line at $49.99/mo, or the Tadalafil + Vardenafil dual-compound for patients who indicated prior monotherapy didn't produce adequate response. Sublingual placement under the tongue 10–15 minutes before sexual activity.
Response should be clear. If Tadalafil monotherapy is producing reliable function, stay there. If partial response, message the prescriber for the dual-compound upgrade — the Vardenafil addition layers a different PDE5 mechanism profile alongside Tadalafil's long-acting effect. The published clinical evidence specifically comparing dual-compound vs single-compound PDE5 protocols is limited — Maximus positions this as a clinical-judgment-driven option, not a default.
For PDE5-responders this is steady-state — periodic refills with the board-certified prescriber. For non-responders even on dual-compound, six months is the point to step back: cardiovascular workup if not done, hormone evaluation (Maximus offers TRT under the same account if low-T contributes), or alternative treatments (shockwave, P-Shot, Trimix) at an in-person clinic. Maximus will refer out for cases beyond PDE5 management.
[Hims](/online-providers/ed-treatment/hims) is the volume-optimized mass-market operation at the lowest per-dose pricing ($4/dose sildenafil, $1.63 Hard Mints chewable). Maximus is the dual-compound-protocol mid-tier at $49.99/mo entry. The price differential is significant — Hims wins on absolute cost floor for monotherapy responders. Maximus wins for patients who haven't fully responded to standard sildenafil/tadalafil monotherapy and want the dual-compound (Tadalafil + Vardenafil) protocol under board-certified physicians. AHF rates Hims 4.1 and Maximus 4.1 (ED) — tie reflects different value propositions matched to different user needs.
[PeterMD](/online-providers/ed-treatment/petermd) offers basic Sildenafil and Tadalafil generics plus the Mt. Everest compounded combo (Tadalafil + Oxytocin + PT-141). Maximus offers Tadalafil monotherapy plus the dual-compound Tadalafil + Vardenafil protocol. Different combo philosophies: PeterMD's Mt. Everest combines a PDE5 with hormone/intimacy-bonding compounds (Oxytocin) and a melanocortin (PT-141); Maximus's dual-compound combines two PDE5 inhibitors with different pharmacokinetic profiles. Both are clinical-judgment-driven upgrade pathways for users where standard monotherapy isn't sufficient. AHF rates PeterMD 4.0 and Maximus 4.1 (ED) — narrow gap reflects Maximus's sublingual delivery + dual-PDE5 differentiation.
Yes — Maximus operates with board-certified physicians and dispenses medications through FDA-registered pharmacy partnerships. The ED line operates under the same infrastructure as their TRT and weight-loss lanes. The active ingredients (tadalafil, vardenafil) are FDA-approved compounds; the proprietary differentiator is the sublingual delivery format combined with the dual-compound protocol option, not the medications themselves. 814+ Trustpilot reviews at 4.2 rating give a meaningful operating-history track record.
Free consultation. Independently reviewed. Board-certified physicians.
Get Free ConsultationSecure telemedicine · HIPAA compliant · Cancel anytime